News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Iovance Biotherapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
2 Bay Area Biotechs That Jumped While Its Peers Cratered
Since Friday, the stock market has been volatile, to say the least.
February 7, 2018
·
2 min read
·
Mark Terry
Biotech Bay
3 Under-the-Radar Bay Area Biotechs That Could Double in 2018
Biotech stocks are generally viewed as highly volatile. Of course, along with volatility comes the possibility for huge upside rewards.
October 18, 2017
·
2 min read
·
Mark Terry
Business
Lion Biotech Raises Approximately $100 Million and Names a New CEO
June 6, 2016
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 17, 2024
May 17, 2024
·
7 min read
Business
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
May 9, 2024
·
18 min read
Business
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
May 1, 2024
·
6 min read
Biotech Bay
Iovance Biotherapeutics to Present at Upcoming Conferences - April 30, 2024
April 30, 2024
·
6 min read
Biotech Bay
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
April 24, 2024
·
7 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - April 19, 2024
April 19, 2024
·
7 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - March 22, 2024
March 22, 2024
·
7 min read
Biotech Bay
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
March 4, 2024
·
7 min read
Biotech Bay
Iovance Biotherapeutics to Present at Upcoming March 2024 Conferences
March 1, 2024
·
6 min read
Business
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
February 28, 2024
·
15 min read
